Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT02215993
Eligibility Criteria:
Inclusion Criteria:
* less than 75 years
* sign the consent form
* Acute coronary syndrome with ST-segment elevation submitted to thrombolysis
Exclusion Criteria:
* use of IIbIIIa inhibitor
* less than 60 kg
* history of stroke
* Patients with sick sinus syndrome, atrioventricular block second or third degree, not protected by pacemaker
* Chronic obstructive pulmonary disease
* Asthma
* Heart failure class III / IV
* renal replacement therapy
* Use of inducers (carbamazepine, phenytoin, phenobarbital, rifampicin and dexamethasone) or inhibitors (ketoconazole, itraconazole, ritonavir, saquinavir, clarithromycin) potent enzyme PYP3A
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
75 Years
Study:
NCT02215993
Study Brief:
Protocol Section:
NCT02215993